Active substances: Norfloxacin
It licensed use in acute and chronic complicated kidney infections has been withdrawn as a result.
CHMP stated that doctors should not prescribe oral norfloxacin for complicated pyelonephritis and should consider switching patients already taking oral norfloxacin for this type of infection to an alternative antibiotic.
Contraindications As noted above, under licensed use, norfloxacin is also now considered to be contraindicated for the treatment of certain sexually transmitted diseases by some experts due to bacterial resistance.
Patients taking any of these drugs concomitantly with norfloxacin should be carefully monitored. Pregnancy Norfloxacin has been reported to rapidly cross the blood-placenta and blood-milk barrier, and is extensively distributed into the fetal tissues.
For this reason norfloxacin and other fluoroquinolones are contraindicated during pregnancy due to the risk of spontaneous abortions and birth defects. The manufacturer only recommends use of norfloxacin during pregnancy when benefit outweighs risk.
Ciprofloxacin is being licensed for the treatment of Complicated Urinary Tract Infections and Pyelonephritis due to Escherichia coli and Inhalational Anthrax post-exposure and levofloxacin was recently licensed for the treatment of Inhalational Anthrax post-exposure.
However, the Fluoroquinolones are licensed to treat lower respiratory infections in children with cystic fibrosis in the UK.
Adverse effects In general, fluoroquinolones are well tolerated, with most side-effects being mild to moderate.
The overall rate of adverse events in patients treated with fluoroquinolones is roughly similar to that seen in patients treated with other antibiotic classes.
If you need an AAP account free for anyone to register an account, please click on "Create Account" below and complete the one-time registration form. Individual Login You will be redirected to aap. Institutional Login This is the touchback warning message modal.
Please read these terms carefully.
In consideration of payment of the applicable subscription fee, the AAP is willing to provide access to the Materials to you and, if applicable, your Users as defined below, subject to all of the following terms.
Access and License.
For individual enrollment use of the Materials is limited solely to you, and you agree not to permit others to access the Materials using your account. You agree not to permit others to access the Materials using your account. You will monitor compliance of your Users with the terms of this Agreement.
The AAP and its Providers do not warrant that access to the Materials or Website will be uninterrupted or error free or that any information, software, or other materials available on or accessible through the Materials or Website is free from viruses, worms, Trojan horses, or other harmful components.
In no event shall the AAP or its Providers be liable for downtime, system speed or slow-down caused by the misoperation or failure of the Internet or any other network not under the sole control of the AAP or by any other cause beyond the reasonable control of the AAP or its Providers.
The AAP will restore access to the Website and Materials as soon as commercially practicable in the event of an unscheduled interruption or failure thereof.
License Restrictions. Changes to the Materials.
The AAP reserves the right at any time, in its discretion, for any reason and without prior notice: i to change, suspend or discontinue any aspect of the Materials, including the availability of any feature, database or content; ii to limit or restrict user access to certain features available on the Materials; and iii to suspend users use of the Materials, temporarily or permanently; provided that in the event any such change materially affects your ability to use the Materials or makes them materially less useful to you, then you may, within thirty 30 days of the change, terminate this Agreement by giving fifteen 15 days written notice to the AAP, and the AAP will refund any unearned portion of your subscription fee.
If the AAP gives you notice that it is withdrawing materials because it no longer retains the right to publish them or that it has reasonable grounds to believe they infringe copyright or are defamatory, obscene, unlawful or otherwise objectionable, then you agree promptly after receipt of such notice to take all commercially reasonable efforts to prevent further access to the applicable Materials by Users.
You agree to pay to the AAP the current subscription fee detailed at enrollment or otherwise provided on the Website, including the then-current fee during any renewal term.
The AAP reserves the right, without prior notice, to suspend your use of the Materials if owed fees are past due.